ICD-10 Coding for Malignant Hypertension(I16.0B, I16.1, I16.1B)
Comprehensive guide on coding malignant hypertension using ICD-10, including criteria for hypertensive emergencies and documentation requirements.
Complete code families applicable to Malignant Hypertension
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| I16.1 | Hypertensive emergency | Use when documentation specifies acute target organ damage with BP ≥180/120 mmHg. |
|
| I10 | Essential (primary) hypertension | Use for 'malignant hypertension' without acute target organ damage. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMalignant Hypertension
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Malignant Hypertension.
Failing to document organ damage for I16.1
Impact
Clinical: Misrepresentation of patient severity., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.
Mitigation
Ensure thorough documentation of clinical findings., Educate staff on coding requirements.
Coding I16.1 for 'malignant HTN' without organ damage.
Impact
Reimbursement: Incorrect DRG assignment leading to potential underpayment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Use I10 unless there is explicit documentation of organ damage.
Hypertensive Emergency Coding
Impact
Risk of incorrect coding without organ damage documentation.
Mitigation
Implement regular audits and staff training.